我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

依达拉奉对瓣膜置换术后患者血流动力学及肝肾功能的影响

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2009年第5期
页码:
721-724
栏目:
临床研究
出版日期:
2009-07-14

文章信息/Info

Title:
Effect of edaravone on hemodynamics and hepatic and renal function in patients with valve replacement
作者:
朱静峰1; 陈锁成1; 孙斌1; 任正兵1; 陈智豫2; 李亚雄2
1.镇江市第一人民医院胸心外科，江苏 镇江 212001；2.昆明市延安医院胸心外科，云南 昆明 650051
Author(s):
ZHU Jing-feng1;  CHEN Suo-cheng1;  SUN Bin1;  REN Zheng-bing1;  CHEN Zhi-yu2;  LI Ya-xiong2
1.Department of Cardiothoracic Surgery, First Peoples Hospital of Zhenjiang, Zhenjiang 212001, Jiangsu, China; 2.Department of Cardiothoracic Surgery, Yanan Hospital, Kunming, Kunming 650051, Yunnan, China
关键词:
依达拉奉; 血流动力学; 肝功能; 肾功能; 体外循环; 缺血/再灌注
Keywords:
edaravone;  hemodynamics;  hepatic function;  renal function;  cardiopulmonary bypass;  ischemic/reperfusion
分类号:
-
DOI:
-
文献标识码:
A
摘要:
目的: 探讨依达拉奉（edaravone,MCI-186）对瓣膜置换术后患者血流动力学以及肝、肾功能的影响。方法: 40例风湿性心脏病行瓣膜置换术的患者随机分为两组，试药组20例，对照组20例。试药组接受MCI-1860.5 mg/kg在主动脉开放前10 min一次性加入体外循环机静脉储血罐中，对照组不接受MCI-186。分别于术前、主动脉开放后2、8和24 h用Swan-Gans漂浮导管监测血流动力学指标，于术前、主动脉开放后8、16和72 h测量血清总胆红素(TBIL)、谷草转氨酶（AST）、谷丙转氨酶（ALT）、血尿素氮（BUN）和肌酐（Cr），记录术后正性肌力药物的应用情况。结果: ①平均动脉压（MAP）、心率（HR）和肺动脉楔压(PAWP)组间比较均无统计学差异；心排指数（CI）在各组中随时间升高，在主动脉开放后8 h试药组高于对照组（P<0.05），且在2 h、24 h更显著（P<0.01）；心脏每搏指数（SVI）、左心室做功指数（LVSWI）在主动脉开放后24 h试药组高于对照组（P<0.05）。②TBIL、AST、ALT、BUN、Cr组间比较均无统计学差异，且各组中BUN、Cr均在正常范围，TBIL、AST、ALT在主动脉开放后72 h亦恢复正常。试药组术后48 h多巴胺平均最大剂量少于C组（P<0.05）。结论: MCI-186能促进瓣膜置换术后患者血流动力学的恢复，改善左室功能，增加心排指数和左室做功指数，对患者肝、肾功能未见明显影响。
Abstract:
AIM: To study the effect of edaravone (MCI-186) on hemodynamics and hepatic and renal function of patients following valve replacement. METHODS: Forty patients with rheumatic heart disease undergoing cardiac valve replacement were randomly divided into two groups. Experimental group (n=20) received edaravone injection (0.5 mg/kg) in venous blood reservoir of cardiopulmonary bypass unit at 10 min before declamping aorta. Control group (n=20) received no edaravone. Hemodynamic parameters were recorded before operation and at 2, 8 and 24 h after declamping aorta and blood samples were taken before operation and at 8, 16 and 72 h after declamping aorta for determination of TBIL, AST, ALT, BUN and Cr. RESULTS: 1)No statistical differences were found in the levels of MAP, HR and PAWP between groups. In both groups, the levels of CI increased at 2, 8 and 24 h, but the levels in experimental group were higher than those in control group at 2 h (P<0.01, 8 h (P<0.05) and 24 h (P<0.01). The levels of SVI and LVSWI at 24 h in experimental group were higher than those in control group (P<0.05). 2)No statistical differences were found in the levels of TBIL, AST, ALT, BUN and Cr between groups, and the levels of BUN and Cr were within the normal range before operation and at 8 h, 16 h and 72 h after in both groups. The levels of TBIL, AST and ALT recovered to normal at 72 h in the two groups. The amount of positive inotropic drugs in experimental group was less than in control group (P<0.05). CONCLUSION: MCI-186, with no significant side effects on hepatic and renal functions, improves the hemodynamic condition and left ventricular functions.

参考文献/References

［1］ An J, Varadarajan SG, Camara A, et al. Blocking Na+/H+ exchange reduces ［Na+］i and ［Ca2+］i load after ischemia and improves function in intact hearts［J］. Am J Physiol Heart Circ Physiol, 2001,281(6):H2398-H2409.

［2］ Tsujita K, Shimomura H, Kaikita K, et al. Long-term efficacy of edaravone in patients with acute myocardial infarction［J］. Circ J, 2006, 70(7):832-837.

［3］ Braunwald E, Kloner RA. Myocardial reperfusion: a double-edged sword?［J］. J Clin Invest, 1985, 76(5):1713-1719.

［4］ Wang LF, Zhang HY. A theoretical investigation on DPPH radical-scavenging mechanism of edaravone［J］. Bioorg Med Chem Lett, 2003, 13(21):3789-3792.

［5］ Watanabe T, Egawa M. Effects of an antistroke agent MCI-186 on cerebral arachidonate cascade［J］. J Pharmacol Exp Ther, 1994, 271(3):1624-1629.

［6］ Tsujita K, Shimomura H, Kawano H, et al. Effects of edaravone on reperfusion injury in patients with acute myocardial infarction［J］. Am J Cardiol, 2004, 94(4):481-484.

［7］ 李军,秦建伟,邵永丰,等. 依达拉奉在体外循环心脏手术中对心肌的保护作用［J］. 中国体外循环杂志， 2005， 3（3）：140-142.

［8］ 彭碧波，朱金如，李功喜，等. 合并乙肝病毒感染的心脏病人体外循环手术适应症探讨［J］. 中华胸心血管外科杂志， 2001， 17（4）：222－224.

［9］ 王宝恩,张定凤． 现代肝脏病学［M］． 北京： 科学出版社， 2003:182.

［10］Coselli JS, LeMaire SA, Miller CC 3rd, et al. Mortality and paraplegia after thoracoabdominal aortic aneurysm repair: a risk factor analysis［J］. Ann Thorac Surg, 2000, 69(2):409-414.

［11］赵东，王敏生，王春生，等. 体外循环术后急性肾功能衰竭的高危因素分析［J］. 中国临床医学， 1999， 6（3）：226-227.

备注/Memo

备注/Memo:
收稿日期：2008-1-24.作者简介：朱静峰，住院医师，硕士Email:zhujingfeng0511@yahoo.com.cn
更新日期/Last Update: 2009-07-22